Hailan Wu

Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjects

Xiaofen Liu, Yuancheng Chen, Haijing Yang et al. · Journal of Infection · 2021 · 57 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Therapeutic Drug Monitoring of Polymyxin B by LC–MS/MS in Plasma and Urine

Xiaofen Liu, Zhenwei Yu, Yu Wang et al. · Bioanalysis · 2020 · 35 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis

Junzhen Wu, Hailan Wu, Yu Wang et al. · Clinical Therapeutics · 2019 · 33 citations

Medicine, Pharmacokinetics, Pharmacology +13

Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients

Li Li, Hailan Wu, Yuancheng Chen et al. · Clinical Therapeutics · 2020 · 30 citations

Medicine, Pharmacokinetics, Pharmacology +12

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae

Zhenwei Yu, Xiaofen Liu, Xiaoxing Du et al. · Frontiers in Pharmacology · 2022 · 25 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17